Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Cogent Biosciences, Inc.
Blueprint Medicines Corporation
Novartis
Deciphera Pharmaceuticals, LLC
Eastern Cooperative Oncology Group
Blueprint Medicines Corporation
GT Biopharma, Inc.
Blueprint Medicines Corporation
Northwestern University
Blueprint Medicines Corporation
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Stanford University
Novartis
Stanford University
Wake Forest University Health Sciences
Children's Oncology Group
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Vanderbilt University Medical Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
Adelphi Values LLC
Novartis
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Asan Medical Center
Vanderbilt-Ingram Cancer Center
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Mayo Clinic
National Cancer Institute (NCI)